FaithEDaviesMD

PubMed

• Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.
  Benjamin Diamond, Dhanvantri Chahar, Michael D Jain, Alexandra M Poos, Michael Durante
  Biorxiv. 2024-11-18
• 1 citations
  Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma.
  Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, Elizabeth Hill, Romanos Sklavenitis-Pistofidis
  Clinical Cancer Research. 2024-10-01
• 2 citations
  The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
  Anthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, Marcella Kaddoura, Marc-Andrea Bärtsch
  Blood. 2024-08-15

Journal Articles

• Sub-Clonal TP53 Copy Number Is Associated with Prognosis in Multiple Myeloma  
  Faith Davies, MD, Blood
• Characterisation of Immunoparesis in Newly Diagnosed Myeloma and Its Impact on Progression-Free and Overall Survival in Both Old and Recent Myeloma Trials  
  Faith Davies, MD, Nature

Abstracts/Posters

• Closing the Efficacy and Effectiveness Gap: Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IR...
  Faith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• The Spectrum of Exomic Mutation in Elderly Myeloma Differs Substantially from Patients at Younger Ages Consistent with a Different Evolutionary Trajectory to Full Blow...
  Faith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab
  Faith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long-Term Outcome of Total Therapy Regimens: Impact of Molecular Subgroups
  Faith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• MALDI-TOF Mass Spectrometry in Serum for the Follow-up of Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Combination Therapy
  Faith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Chromoplexy and Chromothripsis Are Important Prognostically in Myeloma and Deregulate Gene Function By a Range of Mechanisms
  Faith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Mutant KRAS Enhances Stress Granules and Resistance to Proteasome Inhibition Via 15-d-PGJ2 in Multiple Myeloma
  Faith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Analysis of the Sub-Clonal Structure of Smoldering Myeloma over Time Provides a New Means of Disease Monitoring and Highlights Evolutionary Trajectories Leading to Mye...
  Faith E. Davies, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Current Obstacles in Myeloma Management: Debating the Evidence 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Characterisation of Long-Term Responders to First-Line Myeloma Therapy – Results from the UK Myeloma IX and XI Trials 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ixazomib Plus Lenalidomide-Dexamethasone (IRd) in Relapsed/Refractory Multiple Myeloma (MM) Patients (Pts) – Effectiveness in Routine Clinical Practice Is Similar to t... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Baseline and on-Treatment Bone Marrow Microenvironments Predict Myeloma Patient Outcomes and Inform Potential Intervention Strategies 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Extracting Prognostic Molecular Information from PET-CT Imaging of Multiple Myeloma Using Radiomic Approaches 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Proliferation and Molecular Risk Score of Low Risk Myeloma Cells Are Increased in High Risk Microenvironment Via Augmented Bioavailability of Growth Factors 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Mutational Landscape of Primary Plasma Cell Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Future Monoclonal Antibodies: BCMA and Beyond 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
• Join now to see all